6.34 0.07(1.12%)11/19/2024Acrivon Therapeutics, Inc. (ACRV)
| 1 Day | 1 Week | 1 Month | 3 Months | 6 Months | 1 Year | 5 Years | All Time |
| 1.12 | 5.77 | -23.31 | -67.21 | -69.20 | -69.20 | 0.00 | 0.00 |
ACRV reported last earnings on 2024-08-13 after the market.An EPS of $-0.52 was observed compared to an estimated EPS of $-0.59, resulting in a surprise value of $0.07.A revenue of $0 million was observed compared to an estimated revenue of $0 million, resulting in a surprise value of $0 Million.
| Trading Data | |
| Close | 6.34 |
| Open | 6.31 |
| High | 6.49 |
| Low | 6.11 |
| Volume | 35,322 |
| Change | 0.07 |
| Change % | 1.12 |
| Avg Volume (20 Days) | 25,264 |
| Volume/Avg Volume (20 Days) Ratio | 1.40 |
| 52 Week Range | 3.63 - 25.47 |
| Price vs 52 Week High | -75.11% |
| Price vs 52 Week Low | 74.66% |
| Range | 0.00 |
| Gap Up/Down | -0.09 |
Fundamentals | |
| Market Capitalization (Mln) | 249 |
| EBIDTA | 0 |
| PE Ratio | 0.0000 |
| PEG Ratio | 0.0000 |
| WallStreet Target Price | 0.00 |
| Book Value | 0.0000 |
| Earnings Per Share | 0.0000 |
| EPS Estimate Current Quarter | 0.0000 |
| EPS Estimate Next Quarter | 0.0000 |
| EPS Estimate Current Year | 0.0000 |
| EPS Estimate Next Year | 0.0000 |
| Diluted EPS (TTM) | 0.0000 |
| Revenues | |
| Profit Marging | 0.0000 |
| Operating Marging (TTM) | 0.0000 |
| Return on asset (TTM) | 0.0000 |
| Return on equity (TTM) | 0.0000 |
| Revenue TTM | 0 |
| Revenue per share TTM | 0.0000 |
| Quarterly Revenue Growth (YOY) | 0.0000 |
| Quarterly Earnings Growth (YOY) | 0.0000 |
| Gross Profit (TTM) | 0 |
| Dividends | |
| Dividend Share | 0.0000 |
| Dividend Yield | |
| Valuations | |
| Trailing PE | 0.0000 |
| Forward PE | 0.0000 |
| Price Sales (TTM) | 0.0000 |
| Price Book (MRQ) | 0.0000 |
| Revenue Enterprise Value | 0.0000 |
| EBITDA Enterprise Value | 0.0000 |
| Shares | |
| Shares Outstanding | 0 |
| Shares Float | 0 |
| Shares Short | 0 |
| Shares Short (Prior Month) | 0 |
| Shares Ratio | 0.00 |
| Short Outstanding (%) | 0.00 |
| Short Float (%) | 0.00 |
| Insider (%) | 0.00 |
| Institutions (%) | 0.00 |